Orchid Pharma Limited

Web: orchidpharma.com NSE: ORCHPHARMA BSE: 524372 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

876 18(-2%)

Volume

2L as on 23, Jun

Open

1,727

High

1,814

Low

1,720

894

VWAP

987

52 Week High

1,144

52 Week Low

480

Viand Research Rating

Quality Score

33/100

Growth Score

59/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

5,244

No. of Shares

5.99

P/E

69.62

P/B

6.77

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

9.72

ROCE

Profit Growth

Listing Date

02-Nov-20

Rank/Sector Rank

#790/#75

Promoter Holding

69.84%

FII Holding

0.8%

DII Holding

20.75%

Price Chart

Price Performance

1 Week6%

1 Month40%

3 Months94%

6 Months94%

1 Year94%

YTD94%

Moving Average

5 Day SMA994

10 Day SMA960

20 Day SMA885

30 Day SMA827

50 Day SMA737

61 Day SMA698

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,035	971	1,016	1,033
Resistance 2	1,016	967	998	1,015
Resistance 1	987	962	987	986
Pivot Point	969	958	969	968
Support 1	940	954	950	938
Support 2	921	949	939	920
Support 3	892	945	921	891

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(-2.61) 69.84%	(0.01) 72.40%	(-17.61) 72.40%	(0.01) 89.96%	(0.01) 89.96%	(0.01) 89.96%	(0.01) 89.96%	(0.01) 90.00%	(0.01) 90.00%	(0.01) 90.00%
FIIs	(-0.11) 0.80%	(-0.31) 0.87%	(-0.41) 1.17%	(0.21) 1.56%	(-1.31) 1.39%	(0.21) 2.69%	(0.61) 2.53%	(0.51) 1.94%	(-0.51) 1.42%	(-2.21) 1.96%	(-3.91) 4.14%	(-0.51) 8.08%	(7.81) 8.58%	(0.01) 0.81%	(-0.51) 0.86%	(-0.11) 1.37%	(-0.11) 1.48%	(-0.21) 1.61%	(0.01) 1.78%	(0.01) 1.79%
DIIs	(0.51) 20.75%	(0.91) 20.24%	(0.31) 19.38%	(-0.41) 19.04%	(-0.71) 19.43%	(1.11) 20.10%	(0.71) 19.00%	(-0.61) 18.30%	(1.21) 18.93%	(3.21) 17.73%	(2.11) 14.51%	(-1.01) 12.46%	(10.91) 13.48%	(-1.31) 2.62%	(1.01) 3.94%	(0.01) 2.98%	(0.01) 2.97%	(-0.41) 2.97%	(0.01) 3.35%	(0.01) 3.35%
Government	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.04%	0.04%	0.04%
Public	8.62%	9.04%	9.61%	9.57%	9.34%	7.37%	8.63%	9.94%	9.82%	10.47%	11.52%	7.05%	5.54%	6.60%	5.22%	5.69%	5.55%	5.39%	4.84%	4.83%
No. of Shareholders	33,433	35,118	35,709	38,155	39,827	34,303	34,158	36,363	34,695	36,720	36,931	29,197	29,132	29,523	30,894	32,717	33,679	33,698	33,533	34,798

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	304	368	207	194	263	237	217	223	244	217	221	199	183	210	160	165.25	131	178	161	128	92
Sales Growth % (YoY)	15.6%	55.1%	-4.6%	-13.1%	7.7%	9.4%	-1.5%	12%	33.6%	3.4%	38.1%	20.3%	39.6%	17.8%	-1%	29.4%	41.9%	49%	57%	17.7%	-22.5%
Sales Growth % (QoQ)	-17.4%	77.8%	6.7%	-26.2%	11%	9.2%	-2.7%	-8.6%	12.4%	-1.8%	11.1%	8.7%	-12.9%	31.2%	-3.2%	26.1%	-26.4%	10.6%	25.8%	39.1%	-
Expenses	289	336	204	194	269	203	191	193	211	188	185	175	161	170	146	147.43	119	152	147	116	95
Operating Profit	15	32	3	-1	-6	34	26	30	33	29	36	24	22	40	14	17.82	12	26	14	11	-3
OPM %	4.9	9	1.4	-0.3	-2.1	14	12	13	14	13	16	12	12	19	9	10.78	10	14	9	9	-3
Other Income	10	14	3	15	16	6	10	8	8	13	7	8	2	34	9	5.84	3	0	-1	68	3
Interest	2	2	3	4	2	4	4	3	3	3	4	4	6	7	8	9.22	8	4	7	10	11
Depreciation	11	11	9	9	11	9	9	9	8	8	9	8	8	7	8	17.76	22	27	20	20	20
Profit before tax	12	33	-6	2	-2	28	24	26	29	30	31	20	11	59	7	-3.32	-14	-5	-14	49	-31
Tax %	0	0	0	0	0	0	0	0	0	-11	0	0	0	0	0	0	0	0	0	0	0
Net Profit	12	33	-6	2	-2	28	24	26	29	33	31	20	11	59	8	-5.39	-15	-7	-14	49	-31
Net Profit Growth % (QoQ)	-63.6%	650%	-400%	200%	-107.1%	16.7%	-7.7%	-10.3%	-12.1%	6.5%	55%	81.8%	-81.4%	637.5%	248.4%	64.1%	-114.3%	50%	-128.6%	258.1%	-
Net Profit Growth % (YoY)	700%	17.9%	-125%	-92.3%	-106.9%	-15.2%	-22.6%	30%	163.6%	-44.1%	287.5%	471.1%	173.3%	942.9%	157.1%	-111%	51.6%	-	-	-	-
TTM Net Profit	41	27	22	52	76	107	112	119	113	95	121	98	72.61	46.61	-19.39	-41.39	13	-3	4	18	0
EPS in Rs	2.35	6.44	-1.15	0.44	-0.48	5.49	4.71	5.05	5.74	6.54	6.02	3.99	2.13	14.49	1.86	-1.32	-3.68	-1.61	-3.4	12.1	-7.57

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2013	Mar 2012	Jan 1900
Sales	1233	1398	819	666	557	451	481	584	644	755	879	1747	1948	1874	1736
Sales Growth %	-11.8%	70.6%	23%	19.6%	23.6%	-6.3%	-17.6%	-9.4%	-14.7%	-14.1%	-49.4%	-10.3%	4%	5.2%	-
Expenses	1181	1241	708	581	498	392	470	590	622	740	705	1429	1837	1517	1416
Operating Profit	52	157	111	84	59	59	11	-6	22	15	174	317	110	357	320
OPM %	4.2	11	14	13	11	13	2.4	-1.1	3.5	2	20	18	6	19	18
Other Income	35	31	30	57	57	-15	-37	42	20	-59	-28	156	92	52	156
Interest	9	13	17	33	33	52	6	7	310	347	294	537	523	180	537
Depreciation	43	42	33	55	87	109	118	130	133	146	143	325	252	154	321
Profit before tax	35	132	92	54	-5	-117	-150	-101	-401	-537	-292	-389	-573	75	-383
Tax %	0	-7	-4	0	0	0	0	0	-12	-9	-6	-49	-2	-29	-50
Net Profit	35	142	95	54	-5	-117	-150	-101	-355	-489	-274	-197	-560	97	-191
Net Profit Growth %	-75.4%	49.5%	75.9%	1180%	95.7%	22%	-48.5%	71.5%	27.4%	-78.5%	-39.1%	64.8%	-677.3%	150.8%	-
EPS in Rs	6.83	27.98	18.68	13.28	-1.18	-28.7	-36.71	-11.36	-39.94	-54.91	-30.83	-23.06	-79.21	13.84	-22.41
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	22	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2013	Mar 2012
Cash from Operating Activity	142	64	131	13	90	24	80	15	6	402	211	-370	168	737
Cash from Investing Activity	-116	-51	-316	-27	113	67	167	45	-28	-176	-1	1334	-986	-293
Cash from Financing Activity	-41	3	167	31	-217	-165	-250	0	33	-465	-287	-597	664	-480
Net Cash Flow	-15	15	-18	18	-14	-73	-3	60	11	-239	-76	367	-153	-36

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2013	Mar 2012
Equity Capital	15	51	15	51	51	41	41	41	41	89	89	89	89	85	70	70
Reserves	1587	1223	1551	1174	1168	691	637	641	757	-844	-763	-432	82	354	310	1062
Borrowings	129	282	154	165	135	331	268	453	566	3230	3202	3106	3214	3211	3204	2005
Other Liabilities	367	167	366	246	199	160	148	90	86	518	683	595	577	506	1067	801
Total Liabilities	2098	1722	2086	1635	1552	1223	1094	1224	1450	2993	3211	3358	3963	4156	4651	3938
Fixed Assets	671	631	688	650	616	573	584	670	858	1161	1291	1402	1540	1697	2584	2074
CWIP	168	120	44	25	24	46	10	7	26	278	272	288	280	282	360	352
Investments	88	49	80	48	69	50	49	15	0	0	125	125	125	125	1	1
Other Assets	1171	922	1274	912	842	554	452	531	566	1553	1523	1543	2017	2053	1706	1511
Total Assets	2098	1722	2086	1635	1552	1223	1094	1224	1450	2993	3211	3358	3963	4156	4651	3938

Delivery

Delivery Data: ORCHPHARMA

#	Date	872 31% 1144	Value (Cr)	Q/T 12	Del 45	Del 10
1	21-Oct	887	10	10	41	4
2	19-Oct	894	12	10	27	3
3	16-Oct	911	10	9	50	5
4	15-Oct	928	4	9	47	2
5	14-Oct	945	3	8	46	2
6	13-Oct	960	5	7	49	2
7	12-Oct	979	2	8	42	1
8	9-Oct	984	7	7	42	3
9	8-Oct	981	9	4	56	5
10	7-Oct	1024	21	10	32	7
11	6-Oct	1007	7	9	50	3
12	5-Oct	966	7	9	45	3
13	1-Oct	990	9	8	40	4
14	30-Sep	997	6	9	48	3
15	29-Sep	1015	15	8	48	7
16	28-Sep	1023	6	7	43	3
17	25-Sep	1065	7	7	39	3
18	24-Sep	1096	16	11	31	5
19	23-Sep	1102	15	11	36	5
20	22-Sep	1107	55	13	30	17
21	21-Sep	1082	62	18	30	19
22	18-Sep	990	6	17	60	3
23	17-Sep	958	13	17	65	9
24	16-Sep	958	5	10	57	3
25	15-Sep	988	14	10	19	3
26	11-Sep	1003	7	8	61	4
27	10-Sep	1016	4	10	55	2
28	9-Sep	1025	16	19	52	9
29	8-Sep	966	3	13	62	2
30	7-Sep	947	1	10	58	1
31	4-Sep	955	4	13	46	2
32	3-Sep	935	3	15	56	2
33	2-Sep	938	4	13	56	2
34	1-Sep	948	4	7	51	2
35	31-Aug	971	3	12	54	1
36	28-Aug	976	6	13	47	3
37	27-Aug	929	17	12	48	8
38	26-Aug	973	10	8	55	6
39	25-Aug	1039	6	9	59	4
40	24-Aug	1038	15	11	57	8
41	21-Aug	1002	11	14	72	8
42	20-Aug	980	5	10	57	3
43	19-Aug	980	7	11	43	3
44	18-Aug	969	10	11	49	5
45	17-Aug	998	19	11	40	8
46	14-Aug	1046	7	9	47	3
47	13-Aug	1034	6	10	45	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	5,244c	91c	1.71
19-Oct	5,336c	108c	1.98
17-Oct	5,444c	0	0
16-Oct	5,444c	96c	1.73
15-Oct	5,539c	205c	3.57
14-Oct	5,745c	4c	0.07
13-Oct	5,748c	91c	1.55
12-Oct	5,839c	23c	0.40
09-Oct	5,816c	113c	1.90
08-Oct	5,929c	52c	0.88
05-Oct	5,877c	177c	2.92
01-Oct	6,054c	68c	1.14
29-Sep	5,986c	135c	2.20
28-Sep	6,120c	329c	5.10
25-Sep	6,449c	233c	3.48
24-Sep	6,682c	1,103c	19.77
22-Sep	5,579c	609c	12.24
17-Sep	4,971c	196c	3.79
10-Sep	5,166c	351c	7.28
07-Sep	4,816c	0	0

Stock Checklist

Price is above from 52 week high low average: 60%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 52 fund scheme(s) across 9 fund house(s) as of Oct26 · Total value ₹2,016 Cr · 22 increasing / 12 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
quant Mutual Fund	2	0.99%	+0.02%	691.1
Kotak Mahindra Mutual Fund	14	0.35%	-0.01%	476
UTI Mutual Fund	8	1.08%	+0.08%	369
Invesco Mutual Fund	6	0.41%	+0.03%	288.3
Bandhan Mutual Fund	12	0.14%	-0.08%	125.1
PGIM India Mutual Fund	4	0.81%	+0.05%	30.1
Tata Mutual Fund	2	1.15%	+0.11%	28.7
WhiteOak Capital Mutual Fund	2	0.44%	+0.14%	7.5
Motilal Oswal Mutual Fund	2	0.00%	-	0

Orchid Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements